Perhaps the most important clinical setting for this is in patients with renal failure who require parenteral iron ... An abbreviated investigation flow chart is shown in figure 1 and an abbreviated ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

Intensive blood pressure control in hypertensive chronic kidney disease (CKD) provides a survival advantage and other benefits.

Kidneys play a critical role in blood purification and urine production. Common symptoms of kidney damage include swelling of ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Background Iron deficiency (ID) is common in patients with atrial fibrillation/flutter (AF), but its prognostic implications and optimal diagnostic criteria, particularly in those with and without ...

Leveraging new technology in flow cytometry offers oncology labs the opportunity to expand their capabilities beyond diagnosis, giving cancer patients and their physicians precise results ...

After hours: February 7 at 7:59:07 PM EST Loading Chart for ALLO ...

After hours: February 10 at 5:43:59 PM EST Loading Chart for DGX ...